Current Assets. The term "Current Assets" shall mean, with respect to the Company, cash and other assets that are expected to be converted into cash, sold or exchanged within one year from the Closing Date, including marketable securities, receivables, inventory and current prepayments .
Current Assets. Current Assets means the aggregate amount of all the assets of the Borrower and its Subsidiaries, on a consolidated basis, assets which would, in accordance with GAAP, properly be defined as current assets.
Current Assets all assets (1) the value of which is expected to be realized, or intended for sale or use within the normal operating cycle, or (2) which it holds primarily for trading purposes, or (3) the value of which is expected to be realized within the next 12 (twelve) months, or (4) which are cash or cash equivalent, except the cases when their exchange or use to settle a liability is restricted for at least the next 12 (twelve) months.
Current Assets. Acquire current assets for use in, or arising from, the sale of goods or services in the ordinary course of its business (including, for this purpose, but without limitation, credit card receivables);
Current Assets. “Current Assets” shall mean the aggregate amount of the accounts receivable, short-term investments, inventory and prepaid and other current assets of the (including cash and cash equivalents).
Current Assets. 2.2.1 Receivables own BU (BS01_130) Column B of the Novartis Statement of Net Assets represents receivables against other entities within the Novartis division, which are offset by an equivalent amount in the line Payables own BU. These amounts have been eliminated in Column C of the Novartis Statement of Net Assets.
Current Assets. The sum of (a) Accounts Receivable as of the Closing Date which have not been outstanding for more than ninety (90) days, net of any credit balances due to subscribers, and (b)
Current Assets. 2.2.1 Trade receivables (BS01_120) An amount of US$51 million of trade receivables is excluded from this Statement of Net Assets (as reflected in Column F) as it relates to non-Vaccines business activity such as licence fee receivables related to HCV and HIV patents.
Current Assets. 1.8.1 Other receivables related to the target assets described in Sections 1.1, 1.2, 1.3 and 1.4, including deposit of electricity xxxx receivable, guarantee/deposit of venue and premise rental, deposit of property management fee, etc.;
